Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Qiagen ( (QGEN) ) just unveiled an update.
QIAGEN N.V. announced a managerial transaction involving Elaine Mardis, a member of the supervisory body, who received 19,735 common shares through the release of Restricted Stock Units. This transaction was triggered by her decision not to stand for re-appointment to the Supervisory Board. The shares were granted between February 2021 and 2025, with a subsequent net settlement resulting in the receipt of 9,303 common shares after covering related expenses.
The most recent analyst rating on (QGEN) stock is a Hold with a $42.50 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.
More about Qiagen
Average Trading Volume: 1,487,438
Technical Sentiment Signal: Buy
Current Market Cap: $10.28B
For detailed information about QGEN stock, go to TipRanks’ Stock Analysis page.